These findings indicate that Act1 modulates IL-23/IL-21-dependent autoimmunity via suppression of STAT3 activation, providing a mechanism for the association of the SNP-D10N mutation with SLE. Here, TRAF3IP2 is linked to systemic lupus erythematosus.